Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy - Concepedia

Concepedia

Publication | Open Access

Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

DOI Full Paper Access

214

Citations

35

References

2010

Year

Claude Sportès, Rebecca Babb, Michael Krumlauf, Frances T. Hakim, Seth M. Steinberg, Catherine K. Chow, Margaret R. Brown, Thomas A. Fleisher, Pierre Noël, Irina Marić,

Clinical Cancer Research

Abstract

This study shows the potent biological activity of rhIL-7 in humans over a well-tolerated dose range and allows further exploration of its possible therapeutic applications.

References

	Year	Citations

Page 1